universal-vaccine

Cambridge Develops AI-Designed Universal Coronavirus Vaccine

by

Researchers at the University of Cambridge and the spinout firm DIOSynVax have completed the first human trial of a coronavirus vaccine featuring an antigen designed entirely by artificial intelligence. The Phase 1 study, published in the Journal of Infection, confirmed that the candidate, pEVAC-PS, is safe and well-tolerated in 39 healthy participants. While the vaccine … Read more

Cambridge Researchers Test AI-Designed Universal Vaccine

by

The recent breakthrough by the University of Cambridge and its spin-out, DIOSynVax (DVX) Ltd, marks more than just a successful clinical trial; it signals a fundamental shift in how humanity prepares for biological threats. The successful Phase 1 trial of the pEVAC-PS vaccine—an AI-designed, needle-free “universal” coronavirus vaccine—is a preview of a future where we … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]